Latest News in the pharma Industry

Market News

Mylan to launch first generic to EpiPen auto-injector

Mylan to launch first generic to EpiPen auto-injector

29 Aug 2016

List price of $300 per generic EpiPen two-pack carton, which represents a discount of more than 50% to the Mylan list price.

Read more 
Shire's first prescription eye drop, Xiidra 5% now available in the US

Shire's first prescription eye drop, Xiidra 5% now available in the US

29 Aug 2016

Xiidra is the only prescription eye drop approved by the FDA for the treatment of both signs and symptoms of dry eye disease.

Read more 
Elite announces development and license agreement with SunGen Pharma

Elite announces development and license agreement with SunGen Pharma

29 Aug 2016

Companies will collaborate to develop and commercialize four generic products - two CNS stimulants and two beta blockers.

Read more 
RedHill Biopharma receives approval of a European patent supporting RHB-104 for MS

RedHill Biopharma receives approval of a European patent supporting RHB-104 for MS

29 Aug 2016

Patent expected to be valid until 2032, once granted.

Read more 
Impax Laboratories issues voluntary, nationwide recall for one lot of Lamotrigine orally disintegrating tablet 200 mg

Impax Laboratories issues voluntary, nationwide recall for one lot of Lamotrigine orally disintegrating tablet 200 mg

28 Aug 2016

Potential for 100 mg blister cards being packaged in 200 mg containers.

Read more 
NICE recommendation could save the NHS millions

NICE recommendation could save the NHS millions

28 Aug 2016

Approximately 40,000 women in England seek hospital treatment for uterine fibroids every year.

Read more 
Overcoming the challenges of implementing serialization across a diverse pharmaceutical manufacturing environment

Overcoming the challenges of implementing serialization across a diverse pharmaceutical manufacturing environment

28 Aug 2016

New Webinar Hosted by Xtalks.

Read more 
Mylan invalidates two of Teva's Copaxone 40 mg/mL patents

Mylan invalidates two of Teva's Copaxone 40 mg/mL patents

25 Aug 2016

USPTO has ruled in favour of Mylan in its inter partes review proceeding and found all claims of two related Copaxone 40 mg/mL patents to be unpatentable.

Read more 
Recipharm increases lyophilisation capacity in Italy

Recipharm increases lyophilisation capacity in Italy

25 Aug 2016

The investment will see the introduction of a new lyophiliser for vials, increasing the facility’s capacity by approximately 20%.

Read more 
Mylan taking immediate action to further enhance access to EpiPen Auto-Injector

Mylan taking immediate action to further enhance access to EpiPen Auto-Injector

25 Aug 2016

Mylan doubling the eligibility for patient assistance, effectively eliminating out-of-pocket expense for uninsured and under-insured patients.

Read more 
Diabetes and obesity therapeutics market will more than double to $163.2 billion by 2022

Diabetes and obesity therapeutics market will more than double to $163.2 billion by 2022

25 Aug 2016

A number of pipeline T2DM therapeutics are anticipated to be significant contributors to market growth over the forecast period, with some even expected to reach blockbuster status.

Read more 
CPhI’s Pre-Connect Congress outlines current trends in pharma

CPhI’s Pre-Connect Congress outlines current trends in pharma

24 Aug 2016

Patient centricity, combination products, packaging innovation and biotherapeutics showing promise at the forefront of the industry’s development.

Read more